Business Context and Reporting Period
This Form 8-K Current Report was filed by Inpixon (trading symbol: INPX) on September 17, 2019. The registrant is incorporated in Nevada and lists its principal executive offices in Palo Alto, California. The filing primarily discloses the entry into a material definitive agreement involving debt financing and a waiver from an existing lender.
Key Financial Metrics and Transaction Details
- New Debt Instrument: The Company issued an unsecured promissory note with an aggregate principal amount of $952,500.00.
- Proceeds Received: The Company received a purchase price of $750,000.00.
- Discount and Fees: The principal amount includes an original issue discount of $187,500.00 and $15,000.00 in transaction costs (legal, accounting, due diligence).
- Interest Rate: The note accrues interest at 10% per annum.
- Maturity: The note is payable on or before 9 months from the issuance date (approximately June 17, 2020).
- Existing Debt Obligations: As of September 17, 2019, the Company had outstanding balances on prior notes held by the same investor group (Iliad Research And Trading, L.P. and affiliate Chicago Venture Partners, L.P.) totaling approximately $10.258 million ($2.294 million + $3.916 million + $2.132 million + $1.916 million).
- Use of Proceeds: Net proceeds are intended for general working capital purposes.
Material Changes and Terms
The filing details significant terms attached to the new note that differ from standard debt instruments:
- Prepayment Penalty: If the Company prepays the note, it must pay 115% of the portion of the outstanding balance being prepaid.
- Redemption Rights: The Holder has the right to redeem up to 1/3 of the initial principal balance monthly, starting 6 months after issuance.
- Monitoring Fee: A one-time fee of 10% of the then-current outstanding balance will be added if the note remains outstanding on December 17, 2019.
- Default Provisions: A default interest rate of 22% applies. In the event of a Bankruptcy-Related Event of Default, all amounts become immediately due at the "Mandatory Default Amount."
- Right of First Refusal: The Holder has a right of first refusal on future financings involving convertible securities or securities with variable conversion prices.
- Waiver Obtained: The Company secured a waiver from Payplant LLC (agent for Payplant Alternatives Fund LLC) to permit this new transaction under its existing loan agreement.
Management Commentary and Personnel Changes
On September 16, 2019, the Board of Directors appointed Wendy Loundermon as Chief Financial Officer. She had previously served as the principal financial and accounting officer since July 2017. The filing includes standard forward-looking statement disclaimers regarding the benefits of the transaction.
Risks and Contingencies
- Liquidity Pressure: The high cost of capital (10% interest, OID, potential 10% monitoring fee, and 15% prepayment penalty) indicates significant financing costs.
- Redemption Risk: The Holder's ability to demand cash redemption of principal starting in March 2020 could strain liquidity.
- Future Financing Restrictions: The Right of First Refusal and Participation Rights may complicate or delay future capital raises.
Investor Verification Checklist
- Verify the Company's current cash position and ability to meet the potential monthly redemption obligations starting 6 months post-issuance.
- Confirm the total outstanding debt load, including the new $952,500 note and the approximately $10.258 million in existing notes mentioned in the filing.
- Review the "Mandatory Default Amount" definition in the attached Promissory Note (Exhibit 4.1) to understand the full liability in a bankruptcy scenario.
- Assess the impact of the 10% monitoring fee trigger date (December 17, 2019) on the Company's short-term financial planning.
- Check subsequent filings for any exercise of the Holder's redemption rights or new financing activities subject to the Right of First Refusal.